KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Free Cash Flow (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Free Cash Flow readings, the most recent being $816.0 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 126.04% to $816.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.7 billion, a 0.36% change, with the full-year FY2025 number at $6.3 billion, down 13.4% from a year prior.
  • Free Cash Flow hit $816.0 million in Q1 2026 for Thermo Fisher Scientific, down from $3.0 billion in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $3.3 billion in Q4 2023 to a low of $271.0 million in Q2 2023.
  • Median Free Cash Flow over the past 5 years was $1.6 billion (2022), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Free Cash Flow: crashed 82.65% in 2023 and later surged 233.58% in 2024.
  • Thermo Fisher Scientific's Free Cash Flow stood at $2.9 billion in 2022, then increased by 12.97% to $3.3 billion in 2023, then dropped by 15.31% to $2.8 billion in 2024, then grew by 6.48% to $3.0 billion in 2025, then tumbled by 72.73% to $816.0 million in 2026.
  • The last three reported values for Free Cash Flow were $816.0 million (Q1 2026), $3.0 billion (Q4 2025), and $1.8 billion (Q3 2025) per Business Quant data.